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ABSTRACT
Renal transplant patients are treated with immunosuppressive drugs that decrease the effectiveness of the immune system, 
making them more prone to developing cancer. Skin and lip carcinomas are common malignancies encountered after 
transplantation, whereas oral carcinomas are rare. We report the case of a 51-year-old female Caucasian patient, with 
no history of smoking, who presented white lesions on the tongue and an ulcerated lesion on the lower lip beginning 
4  months prior. Diagnosis of squamous cell carcinoma for both lesions was made following incisional biopsies. Interestingly, 
the patient reported a renal transplantation 23 years prior, and was maintained on a combination of cyclosporine, 
mycophenolate sodium and prednisone. The patient also presented a history of several basal and squamous cell carcinomas 
on sun-exposed areas of the skin. Both lesions were surgically excised. No sign of recurrence or new lesions in the oral 
cavity have been observed; however, new skin lesions are frequently diagnosed. This case report highlights that oral 
cancers may occur in transplant patients in the absence of classical risk factors. Thus, clinicians must be aware of the 
importance of thorough oral examination in transplant patients in routine follow-up. 
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INTRODUCTION
Renal transplantation is the treatment of choice 
for patients with end-stage renal disease, which 
may improve their survival rate and quality of life.1,2 
However, renal transplantation also increases the risk 
of cancer,3 with a 5% to 6% increase in the incidence 
of cancer when compared to the general population.4 
This can be attributed to the alteration of immune 
surveillance mechanisms due to the chronic use of 
immunosuppressive therapy and infection by oncogenic 
viruses.4-6 About 13% of transplanted patients develop 
cancer;7 however, the risk of malignancies is not the 
same for all types of cancer.8
Cancers of the skin and lip have been described 
to occur at a higher incidence9 among transplanted 
patients; however, the incidence of oral carcinomas, 
especially in the tongue, is scarcely reported in the 
literature.10-14 The current report presents the case 
of a renal transplant patient who developed multiple 
carcinomas in the skin with synchronous development 
of lip and tongue carcinomas, highlighting the 
importance of oral examination in the follow-up of 
these patients.
CASE REPORT
A 51-year-old female patient was referred for 
evaluation of white lesions on the tongue and ulcerated 
lesions on the lower lip that had developed over the past 
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4 months. She denied smoking and consuming alcohol. 
She had been diagnosed with systemic erythematous 
lupus (SLE), and lost renal function as a result of 
lupus nephritis. The patient had undergone renal 
transplantation 23 years prior, and was on continuous 
post-transplant immunosuppressive therapy with a 
combination of cyclosporine, mycophenolate sodium 
and prednisone.
On physical examination, numerous skin scars 
were observed due to the surgical removal of basal 
cell carcinomas (BCCs) and squamous cell carcinomas 
(SCCs) that developed during immunosuppressive 
therapy, especially on the upper limbs and face. 
The lower lip showed an erythematous area with central 
ulceration. On intraoral examination, a heterogeneous 
and slightly corrugated white plaque was observed on 
the ventral surface of the tongue (Figure 1).
Incisional biopsies of the lip and the tongue were 
performed under local anesthesia. The diagnosis of 
SCC was established, and the patient was referred to 
a head and neck surgeon who surgically removed both 
lesions (Figure 2).
After 5 years of follow-up, the patient developed 
SCC on the forearm, hand, neck, finger, scalp, cheek, 
leg, nose and temporal region. BCCs developed on the 
nose, thorax, lower eyelid and upper back.
All tumors that had presented since renal 
transplantation are listed in Table 1.
The patient is on regular follow-up, and no 
signs of recurrence or new primary tumors in the oral 
cavity have been observed. However, the patient has 
undergone removal of several carcinomas (BCCs and 
SCCs) of the skin, and future biopsies for new lesions 
on the nose and forehead are scheduled. The patient 
signed a declaration of consent in accordance with the 
standard institutional protocol.
DISCUSSION
Renal transplantation is the ultimate treatment 
option for kidney failure, aiming to improve the patient’s 
quality of life. However, there are some complications 
related to immunosuppressive maintenance therapy, 
such as increased susceptibility to infections and a 
higher risk of cardiovascular disease and malignancies.15 
The development of cancer is a significant complication 
of renal transplantation. The higher likelihood of 
developing cancer4 can be attributed to the maintenance 
immunosuppressive therapy.16,17
Some immunosuppressive drugs may potentiate 
the action of carcinogens, independent of their effects 
on immune cells,18 while others are related to cellular 
changes and the development of malignancies. 
Cyclosporine inhibits DNA repair and apoptosis in 
human keratinocytes exposed to UVB radiation,19,20 and 
prednisone may be associated with a higher probability 
of malignancy by diminishing DNA repair mechanisms.21 
Studies22,23 suggest that immunosuppressive agents 
may be involved in the activation of mechanisms 
of the tumor growth, such as transforming growth 
factor alpha and vascular endothelial growth factor. 
Moreover, withdraw of immunosuppressive therapy 
in case of transplantation failure is associated with 
an immediate reduction in the risk of some cancers, 
such as lip cancer, melanoma and non-Hodgkin’s 
Figure 1. Gross view of the lesions at the time of diagnosis. A - Ulcerated lesion on the lower lip. B - White patch 
on the ventral surface of the tongue.
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Figure 2. Histopathological aspects of squamous cell carcinoma. A - Microinvasive tumor of the tongue. B - Tumor 
cells in the connective tissue of the lower lip.
Table 1. All tumors presented by the patient from renal transplantation to the time of diagnosis of oral lesions
Number of the tumor
Histopathologic  
Diagnosis
Location
Years after  
transplantation
1 SCC Face 8
2 BCC Skin of lower lip 11
3 BCC Skin of lower lip 11
4 SCC Skin of lower lip 12
5 BCC Pre auricular 15
6 BCC Parietal region 15
7 SCC Occipital region 15
8 SCC Skin of lower lip 15
9 SCC Dorsal of hand 15
10 SCC Scalp 16
11 SCC Skin below the eye 17
12 SCC (in situ) Nose (right) 17
13 BCC Nose (left) 17
14 SCC Ventral tongue 18
15 SCC Lower lip 18
16 SCC (in situ) Scalp 18
17 SCC Scalp 18
18 SCC Right hand 19
19 SCC Neck 20
20 SCC IV finger 20
21 SCC Scalp 21
22 SCC Cheek 23
23 BCC Nose 23
24 BCC Forehead 23
25 SCC Leg 23
26 BCC Thorax 23
27 SCC Left arm 23
28 BCC Lower eyelid 23
29 SCC Nose 23
30 BCC Upper back 23
31 SCC Temporal region 23
SCC: squamous cell carcinoma; BCC: basal cell carcinoma.
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lymphoma.23,24 The synergic effect between UV 
radiation and immunosuppressive therapy can be 
observed in lesions related to sunlight exposure, such 
as skin and lip cancers.25 In the present report, the 
patient was under continuous cyclosporin treatment 
for 23 years in association with mycophenolate sodium 
and prednisone, and she developed lip and tongue 
SCCs in addition to multiple skin carcinomas.
Systemic erythematous lupus has been associated 
with an increased risk of cancer. Nevertheless, the 
specific cause is not clear, and may be attributed 
to dysregulation of the immune system or a side 
effect of the immunosuppressive medication used 
for treatment.26 A recent systematic review and 
meta-analysis27 on the risks of cancer development 
in SLE patients concluded that SLE is associated with 
an increased risk of cancer in general, particularly 
hematological, reproductive, digestive and respiratory 
cancers in women and men. However, lip and tongue 
cancers were not cited by this study. On the other hand, 
a clinical case of tongue cancer has been reported in 
the English literature in a pregnant woman with SLE, 
who had classic high-risk habits for the development 
of oral carcinoma, which makes the association with 
lupus questionable.26
In contrast to SCCs, BCCs are the most common 
type of skin cancer worldwide. However, skin SCCs can 
occur up to 25 times more frequently in transplanted 
patients.28 The association between immunosuppression 
and sun exposure can be evidenced in our case, as 
our patient developed multiple skin carcinomas in 
sun-exposed areas, especially in the head and neck 
region.
Lip cancer development has also been described as 
a common consequence of renal transplantation.18,25,29,30 
Lip carcinoma is more common in Caucasians chronically 
exposed to the sunlight, and almost all lip SCCs are 
associated with areas of actinic cheilitis.18,25,31,32 
The patient in our case report presented fair skin and 
a history of sunlight-exposure with a delayed habit of 
UV protection. The combination of these factors with 
immunosuppressive therapy seems to have contributed 
to the development of these tumors. Interestingly, 
although lip SCCs are typically associated with severe 
actinic cheilitis features, such as red spots, white plates, 
hardening and loss of vermilion border definition, the 
current patient only had mild actinic cheilitis.
Although SCC of the tongue is the most frequent 
oral malignancy in the general population, it seems to 
be rare in renal transplant patients.10-14 While tobacco 
and alcohol consumption are the most important 
risk factors for these lesions, diet, nutrition, viruses 
and genetic predisposition have also been associated 
with SCC.33 In general, oral SCCs are more frequently 
observed in adult male patients with a heavy smoking 
habit and alcohol consumption.34 The profile of risk 
factors for oral SCCs in transplanted patients are 
different from those of the general population, and to 
the best of our knowledge, all reports in the English 
literature do not resemble the traditional pattern of 
oral SCCs (Table 2).
The present report is the only case of a tongue 
SCC in a female transplanted patient without classical 
risk factors (tobacco and alcohol) published in the 
literature. In addition, this case presented a longer 
post-transplant period for tongue SCC development 
(23 years) compared to the average of 9.4 years among 
the reported cases.
Table 2. Reports on oral SCCs in transplanted patients published in the English literature and their respective findings
Author Gender Age (y)
Time since renal 
transplantation (y)
Tobacco 
use
Alcohol 
abuse
Immunosuppressive 
drugs
Lee & Gisser10 Male 26 9 No No Azt / Pred
Meng11
Male 55 7 No No Azt/ Cyc/ Pred
Male 40 11 No No Azt/ Cyc/ Pred
Male 52 11 No No Azt/ Cyc/ Pred
Zhang et al.12 Male 65 8 No No Azt/Cyc/Pred
Malleshappa13 Male 30 9 No No Azt/ Cyc/ Pred
Prakash14 Male 46 11 No No Azt/ Cyc / Steroids
Current case Female 51 23 No No Cyc / Pred / Myc/
Azt: Azathioprine; Pred: Predinisolone; Cyc: Cyclosporine; Myc: Mycophenolate sodium; y: year.
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After renal transplantation, malignant diseases are 
more difficult to control, and the surgical principles for 
early-stage tongue cancer in these cases are similar to 
advanced-stage cases due to the low immune states 
that facilitate tumor metastasis and severe infection 
after surgery.11 The reported patient showed no 
signs of metastasis or local recurrence, which may be 
explained by the early diagnosis and, consequently, 
better prognosis.
In conclusion, Caucasian transplant patients with 
a history of sunlight exposure have a higher propensity 
to develop lower lip and skin cancer. In addition, 
although rare, oral cancer can also be observed in 
this group of patients, even after a long follow-up 
period. Thus, clinicians must be aware of the necessity 
and importance of oral examination of transplanted 
patients, and a regular and close follow-up should be 
enforced.
The patient has signed the consent declaration as 
to the Institutional standard protocol.
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